Successful fast track protocol implementation for patients undergoing transapical transcatheter aortic valve implantation

Table 1 Baseline demographic and clinical characteristics of group S (successful fast-track protocol) and group F (fast track protocol failure)

	Group S (n = 172)		Group F (n = 35)
	No.	%	No.	%
Variables					p
Age (years)	79.2 ± 6.1		86.5 ± 2.6		0.008
Male	88	51	25	71	0.04
STS risk score	8.2 ± 6.8		11.4 ± 8.4		0.18
Log. EuroSCORE	23.2 ± 9.7		25.8 ± 8.3		0.46
Atrial fibrillation	50	29	9	27	0.26
Diabetes	34	20	12	35	0.11
Arterial Hypertension	160	93	29	82	0.21
Pulmonary Hypertension	115	67	26	75	0.25
Previous stroke	26	15	6	17	0.15
Peripheral vascular disease	46	27	14	40	0.08
COPD	53	31	16	47	0.17
Chronic renal failure	91	53	29	82	0.31
Mean ejection fraction (%)	47 ± 15		31 ± 5		0.05
Mean pressure gradient (echo; mmHg)	51 ± 19		44 ± 27		0.14
Aortic valve area (cm)	0.66 ± 0.22		0.72 ± 0.48		0.09
Previous cardiac surgery	50	29	12	35	0.29
Preop. MV regurgitation (moderate to severe)	20	11	12	35	0.05

COPD chronic obstructive pulmonary disease, Chronic renal failure = glomerular filtration rate < 60 ml/min/1.73 m²; EuroSCORE European system for cardiac risk evaluation, Group F fast track protocol failure, Group S successful fast-track protocol, MV mitral valve, STS risk score The Society of Thoracic Surgeons’ risk sore

ISSN: 1749-8090